Matthew T McMillan1, Brett L Ecker1, Stephen W Behrman2, Mark P Callery3, John D Christein4, Jeffrey A Drebin1, Douglas L Fraker1, Tara S Kent3, Major K Lee1, Robert E Roses1, Michael H Sprys1, Charles M Vollmer5. 1. Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. 2. Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA. 3. Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. 4. Department of Surgery, University of Alabama School of Medicine, Birmingham, AL, USA. 5. Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. Charles.Vollmer@uphs.upenn.edu.
Abstract
BACKGROUND: Evidence suggests externalized trans-anastomotic stents may be beneficial as a fistula mitigation strategy for pancreatoduodenectomy (PD); however, previous studies have not been rigorously risk-adjusted. METHODS: From 2001 to 2015, PDs were performed at three institutions, with externalized stents placed at the surgeon's discretion. The Fistula Risk Score (FRS) and the Modified Accordion Severity Grading System were used to analyze occurrence and severity of clinically relevant postoperative pancreatic fistula (CR-POPF) across various risk scenarios. RESULTS: Of 729 PDs, externalized stents were placed during 129 (17.7 %). Overall, CR-POPFs occurred in 77 (10.6 %) patients. The median FRS of patients who received externalized stents was significantly higher compared with patients who did not (6 vs. 3, p < 0.0001). Patients with negligible, low, or moderate CR-POPF risk (FRS 0-6) did not demonstrate improved outcomes with externalized stents; however, among high-risk patients (FRS 7-10), stents were associated with significantly reduced rates of CR-POPF (14.0 vs. 36.4 %, p = 0.031), severe complications (p = 0.039), and hospital stay (p = 0.014) compared with no stents. The average complication burden of CR-POPF was significantly lower for patients with externalized stents (p = 0.035). CONCLUSION: This multicenter study, the largest comparative analysis of externalized trans-anastomotic stents versus no stent for PD, demonstrates a risk-stratified benefit to externalized stents.
BACKGROUND: Evidence suggests externalized trans-anastomotic stents may be beneficial as a fistula mitigation strategy for pancreatoduodenectomy (PD); however, previous studies have not been rigorously risk-adjusted. METHODS: From 2001 to 2015, PDs were performed at three institutions, with externalized stents placed at the surgeon's discretion. The Fistula Risk Score (FRS) and the Modified Accordion Severity Grading System were used to analyze occurrence and severity of clinically relevant postoperative pancreatic fistula (CR-POPF) across various risk scenarios. RESULTS: Of 729 PDs, externalized stents were placed during 129 (17.7 %). Overall, CR-POPFs occurred in 77 (10.6 %) patients. The median FRS of patients who received externalized stents was significantly higher compared with patients who did not (6 vs. 3, p < 0.0001). Patients with negligible, low, or moderate CR-POPF risk (FRS 0-6) did not demonstrate improved outcomes with externalized stents; however, among high-risk patients (FRS 7-10), stents were associated with significantly reduced rates of CR-POPF (14.0 vs. 36.4 %, p = 0.031), severe complications (p = 0.039), and hospital stay (p = 0.014) compared with no stents. The average complication burden of CR-POPF was significantly lower for patients with externalized stents (p = 0.035). CONCLUSION: This multicenter study, the largest comparative analysis of externalized trans-anastomotic stents versus no stent for PD, demonstrates a risk-stratified benefit to externalized stents.
Authors: Jordan M Winter; John L Cameron; Kurtis A Campbell; David C Chang; Taylor S Riall; Richard D Schulick; Michael A Choti; JoAnn Coleman; Mary B Hodgin; Patricia K Sauter; Christopher J Sonnenday; Christopher L Wolfgang; Michael R Marohn; Charles J Yeo Journal: J Gastrointest Surg Date: 2006-11 Impact factor: 3.452
Authors: Charles M Vollmer; Russell S Lewis; Bruce L Hall; John D Allendorf; Joal D Beane; Stephen W Behrman; Mark P Callery; John D Christein; Jeffrey A Drebin; Irene Epelboym; Jin He; Henry A Pitt; Emily Winslow; Christopher Wolfgang; Steven M Strasberg Journal: Ann Surg Date: 2015-03 Impact factor: 12.969
Authors: Matthew T McMillan; Sameer Soi; Horacio J Asbun; Chad G Ball; Claudio Bassi; Joal D Beane; Stephen W Behrman; Adam C Berger; Mark Bloomston; Mark P Callery; John D Christein; Elijah Dixon; Jeffrey A Drebin; Carlos Fernandez-Del Castillo; William E Fisher; Zhi Ven Fong; Michael G House; Steven J Hughes; Tara S Kent; John W Kunstman; Giuseppe Malleo; Benjamin C Miller; Ronald R Salem; Kevin Soares; Vicente Valero; Christopher L Wolfgang; Charles M Vollmer Journal: Ann Surg Date: 2016-08 Impact factor: 12.969
Authors: Patrick Pessaux; Alain Sauvanet; Christophe Mariette; François Paye; Fabrice Muscari; Antonio Sa Cunha; Bernard Sastre; Jean-Pierre Arnaud Journal: Ann Surg Date: 2011-05 Impact factor: 12.969
Authors: Matthew T McMillan; John D Christein; Mark P Callery; Stephen W Behrman; Jeffrey A Drebin; Tara S Kent; Benjamin C Miller; Russell S Lewis; Charles M Vollmer Journal: HPB (Oxford) Date: 2014-07-10 Impact factor: 3.647
Authors: J-Y Jang; Y R Chang; S-W Kim; S H Choi; S J Park; S E Lee; C-S Lim; M J Kang; H Lee; J S Heo Journal: Br J Surg Date: 2016-04-04 Impact factor: 6.939
Authors: Thomas F Seykora; Laura Maggino; Giuseppe Malleo; Major K Lee; Robert Roses; Roberto Salvia; Claudio Bassi; Charles M Vollmer Journal: J Gastrointest Surg Date: 2018-11-07 Impact factor: 3.452
Authors: Brett L Ecker; Matthew T McMillan; Laura Maggino; Valentina Allegrini; Horacio J Asbun; Chad G Ball; Claudio Bassi; Joal D Beane; Stephen W Behrman; Adam C Berger; Mark Bloomston; Mark P Callery; John D Christein; Euan Dickson; Elijah Dixon; Jeffrey A Drebin; Carlos Fernandez-Del Castillo; William E Fisher; Zhi Ven Fong; Ericka Haverick; Robert H Hollis; Michael G House; Steven J Hughes; Nigel B Jamieson; Tara S Kent; Stacy J Kowalsky; John W Kunstman; Giuseppe Malleo; Ronald R Salem; Kevin C Soares; Vicente Valero; Ammara A Watkins; Christopher L Wolfgang; Amer H Zureikat; Charles M Vollmer Journal: J Gastrointest Surg Date: 2017-08-24 Impact factor: 3.452
Authors: Vincenzo Mazzaferro; Matteo Virdis; Carlo Sposito; Christian Cotsoglou; Michele Droz Dit Busset; Marco Bongini; Maria Flores; Natalie Prinzi; Jorgelina Coppa Journal: Ann Surg Date: 2019-11 Impact factor: 12.969
Authors: Marco V Marino; Adrian Kah Heng Chiow; Antonello Mirabella; Gianpaolo Vaccarella; Andrzej L Komorowski Journal: J Clin Med Date: 2021-05-18 Impact factor: 4.241